High Quality for Gentamicin 0 3 - dexamethasone sodium phosphate injection – Xinanran
High Quality for Gentamicin 0 3 - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
Our enterprise aims to operating faithfully, serving to all of our prospects , and working in new technology and new machine frequently for High Quality for Gentamicin 0 3 - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: Hyderabad, Istanbul, Saudi Arabia, We hope we can establish long-term cooperation with all of the customers, and hope we can improve competitiveness and achieve the win-win situation together with the customers. We sincerely welcome the customers from all over the world to contact us for anything you need!Welcome all customers both at home and abroad to visit our factory. We hope to have win-win business relationships with you, and create a better tomorrow.
By Albert from Sri Lanka - 2017.08.16 13:39
Products and services are very good, our leader is very satisfied with this procurement, it is better than we expected,
By Christine from Romania - 2017.03.07 13:42